The REAC® Technology (Radio Electric Asymmetric Conveyer) is an innovation in the field of neurobiological and tissue treatments that arises from a international invention patent for therapeutic use rebalancing the body's bioelectric activity.
This activity is essential for all physiological functions, from communication between cells to regulation of metabolic processes. Alterations of this delicate bioelectric balance, caused by inflammatory, traumatic, degenerative or epigenetic factors, can contribute to the onset or aggravation of disorders and pathologies.
The mechanism of action of the technology consists in the emission into the environment of very low-intensity radioelectric fields suitably modulated and asymmetrically conveyed to the patient's body through specific electrodes.
The goal is to optimize ion flows at the cellular level, restoring proper cellular polarity and improving cellular communication. In essence, REAC® Technology aims to rebalance biological functions to promote the body's natural processes of self-healing and adaptation.
It is a safe, non-invasive, painless and free of significant side effects.
Up PubMed Numerous scientific publications are available demonstrating the safety and efficacy of treatments in multiple clinical settings. Each publication offers an in-depth analysis of the mechanisms of action and the clinical results obtained, confirming the value of REAC® Technology as an innovative therapeutic tool. We invite you to explore these works to understand the solid scientific foundations that guide our daily commitment to health and well-being.
EN 
IT 
PT 
DE 
ES 
FR 